StockData
Savara Inc logo

Savara Inc (SVRA) stock

SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$4.72+0.24 (+5.36%)

Close on Nov 18, 2026Market cap $969.77MP/E –Yield –

Savara pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Savara

Savara has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Savara figures

See a number that looks wrong?